Marco Moretti

2.4k total citations
34 papers, 447 citations indexed

About

Marco Moretti is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Marco Moretti has authored 34 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 9 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Marco Moretti's work include COVID-19 Clinical Research Studies (5 papers), Pneumonia and Respiratory Infections (5 papers) and Nosocomial Infections in ICU (5 papers). Marco Moretti is often cited by papers focused on COVID-19 Clinical Research Studies (5 papers), Pneumonia and Respiratory Infections (5 papers) and Nosocomial Infections in ICU (5 papers). Marco Moretti collaborates with scholars based in Italy, Belgium and Lebanon. Marco Moretti's co-authors include F. Mantovani, Mauro Ercolani, Alessandro Agostini, Denis Piérard, Massimo Campieri, Johan Van Laethem, Giulia Matacchione, Antonio Domenico Procopio, Jacopo Sabbatinelli and Angelica Giuliani and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Urology and Nutrients.

In The Last Decade

Marco Moretti

30 papers receiving 439 citations

Peers

Marco Moretti
Kelly Fleetwood United Kingdom
Douglass B. Clayton United States
Michele Marconi Italy
V. Boddi Italy
Seung Ki Min South Korea
Jaime A. Cavallo United States
T. Keefe Davis United States
Andréa Lasserre France
Lawrence S. Ross United States
Amy Lyons United States
Kelly Fleetwood United Kingdom
Marco Moretti
Citations per year, relative to Marco Moretti Marco Moretti (= 1×) peers Kelly Fleetwood

Countries citing papers authored by Marco Moretti

Since Specialization
Citations

This map shows the geographic impact of Marco Moretti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Moretti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Moretti more than expected).

Fields of papers citing papers by Marco Moretti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Moretti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Moretti. The network helps show where Marco Moretti may publish in the future.

Co-authorship network of co-authors of Marco Moretti

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Moretti. A scholar is included among the top collaborators of Marco Moretti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Moretti. Marco Moretti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moretti, Marco, et al.. (2025). The role of EIP-AGRI Operational Groups as a driver for innovation in viticulture. ECONOMIA AGRO-ALIMENTARE. 215–243. 1 indexed citations
2.
Pulvirenti, Alfredo, Marco Moretti, Simona Gatti, et al.. (2024). Diagnostic Accuracy of IgA Anti-Transglutaminase Assessed by Chemiluminescence: A Systematic Review and Meta-Analysis. Nutrients. 16(15). 2427–2427. 4 indexed citations
3.
D’Errico, Marcello Mario, et al.. (2024). Outbreak of Ralstonia spp. and Burkholderia spp. Catheter-Related Bloodstream Infection in Hemodialysis Unit. SHILAP Revista de lepidopterología. 4(3). 144–151. 1 indexed citations
4.
Lefesvre, Pierre, et al.. (2024). The challenges in lymphogranuloma venereum diagnosis whether NAAT is negative, a case series. International Journal of STD & AIDS. 36(4). 283–288.
5.
Cirilli, Natalia, Rosaria Gesuita, Luca Tiano, et al.. (2024). Role of viable but non culturable cells in patients with cystic fibrosis in the era of highly effective modulator therapy. Journal of Cystic Fibrosis. 23(6). 1153–1158. 2 indexed citations
6.
Moretti, Marco, Antônio Mauro Rezende, Sabine Zange, et al.. (2024). Breakthrough Mpox Outbreak Investigation, the Delicate Balance Between Host Immune Response and Viral Immune Escape. Sexually Transmitted Diseases. 51(7). 499–503. 2 indexed citations
7.
8.
Moretti, Marco, Florence Crombé, Kurt Barbé, et al.. (2024). Five-year VIM-producing Pseudomonas aeruginosa outbreak in four Belgian ICUs, an investigation report (2019-2023). American Journal of Infection Control. 52(12). 1425–1431. 4 indexed citations
9.
Moretti, Marco, et al.. (2023). Therapeutical strategies in cavitary legionnaires’ disease, two cases from the field and a systematic review. Annals of Clinical Microbiology and Antimicrobials. 22(1). 105–105. 1 indexed citations
10.
Sabbatinelli, Jacopo, Mirko Di Rosa, Angelica Giuliani, et al.. (2023). Serum levels of soluble suppression of tumorigenicity 2 (sST2) and heart-type fatty acid binding protein (H-FABP) independently predict in-hospital mortality in geriatric patients with COVID-19. Mechanisms of Ageing and Development. 216. 111876–111876. 1 indexed citations
11.
Sabbatinelli, Jacopo, Angelica Giuliani, Anna Rita Bonfigli, et al.. (2022). Prognostic value of soluble ST2, high-sensitivity cardiac troponin, and NT-proBNP in type 2 diabetes: a 15-year retrospective study. Cardiovascular Diabetology. 21(1). 180–180. 23 indexed citations
12.
Faro, Alfredo Fabrizio Lo, Anastasio Tini, Filippo Pirani, et al.. (2022). Quantification of Carbonic Anhydrase Inhibitors and Metabolites in Urine and Hair of Patients and Their Relatives. Biology. 11(10). 1379–1379. 3 indexed citations
13.
Moretti, Marco, Johan Van Laethem, Andrea Minini, Denis Piérard, & Manu L. N. G. Malbrain. (2021). Ventilator-associated bacterial pneumonia in coronavirus 2019 disease, a retrospective monocentric cohort study. Journal of Infection and Chemotherapy. 27(6). 826–833. 36 indexed citations
14.
15.
Moretti, Marco, et al.. (2021). Fear for CoViD-19 and reluctance to work among health care workers during the epidemic, a prospective monocentric cohort study. American Journal of Infection Control. 50(3). 312–318. 5 indexed citations
16.
Cantini, Luca, Federica Pecci, Giovanni Belletti, et al.. (2021). Seroprevalence of SARS-CoV-2–Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy. Journal of Clinical Medicine. 10(7). 1503–1503. 9 indexed citations
17.
Sabbatinelli, Jacopo, Angelica Giuliani, Giulia Matacchione, et al.. (2020). Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients. Mechanisms of Ageing and Development. 193. 111413–111413. 87 indexed citations
18.
Agostini, Alessandro, Marco Moretti, Carlo Calabrese, et al.. (2014). Attachment and quality of life in patients with inflammatory bowel disease. International Journal of Colorectal Disease. 29(10). 1291–1296. 36 indexed citations
19.
Anastasio, Gerardo, et al.. (2013). One-step Laparoscopic and Endoscopic Treatment of Gallbladder and Common Bile Duct Stones: Our Experience of the Last 9 Years in a Retrospective Study. The American Surgeon. 79(12). 1243–1247. 8 indexed citations
20.
Mantovani, F., et al.. (2007). Adjustable Suburethral Sling (Male Remeex System®) in the Treatment of Male Stress Urinary Incontinence: A Multicentric European Study. European Urology. 52(5). 1473–1480. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kelly Fleetwood Breakdown of academic impact, for papers by Douglass B. Clayton Breakdown of academic impact, for papers by Michele Marconi Breakdown of academic impact, for papers by V. Boddi Breakdown of academic impact, for papers by Seung Ki Min Breakdown of academic impact, for papers by Jaime A. Cavallo Breakdown of academic impact, for papers by T. Keefe Davis Breakdown of academic impact, for papers by Andréa Lasserre Breakdown of academic impact, for papers by Lawrence S. Ross Breakdown of academic impact, for papers by Amy Lyons
Rankless by CCL
2026